title: STROBE-based methodology for detection of adverse events across multiple communities.
abstract: Partners Healthcare is one of five institutions in conjunction with eHealth Initiative (eHI) and the FDA that is collaborating in a nation-wide effort to develop novel health information technology tools to create an active drug safety surveillance system across the U.S. The STROBE statement serves as the standard for the definition of a structured, systematic, reproducible approach for detecting both the risks and benefits of drug treatments in multiple settings.
authors.affiliation: Massachusetts General Hospital, Partners Healthcare, Boston, MA, USA.
authors.forename: Margarita
authors.initials: M
authors.lastname: Sordo
authors.forename: Judith
authors.initials: J
authors.lastname: Colecchi
authors.forename: Anil
authors.initials: A
authors.lastname: Dubey
authors.forename: Anil Kumar
authors.initials: AK
authors.lastname: Dubey
authors.forename: Vivian
authors.initials: V
authors.lastname: Gainer
authors.forename: Shawn N
authors.initials: SN
authors.lastname: Murphy
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D019058:Community Networks / Q000458:organization & administration*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000145:classification*; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D008404:Massachusetts; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors